Highbridge Capital Management’s Elevance Health ELV Stock Holding History

Highbridge Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,300	Closed	-$297K	–	1320
2017 Q4	$297K	Buy	+1,300	New	+$277K	0.01%	1243
2017 Q1	–	Sell	-6,900	Closed	-$993K	–	1490
2016 Q4	$993K	Buy	6,900 +3,800	+123%	+$509K	0.02%	547
2016 Q3	$389K	Buy	+3,100	New	+$400K	0.01%	898
2016 Q1	–	Sell	-2,500	Closed	-$349K	–	1571
2015 Q4	$349K	Buy	+2,500	New	+$344K	0.01%	1128
2014 Q2	–	Sell	-2,600	Closed	-$260K	–	1119
2014 Q1	$260K	Buy	+2,600	New	+$235K	﹤0.01%	896

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Highbridge Capital Management's ELV Position: Q1 2018 in Review

Highbridge Capital Management sold out of Elevance Health (ELV) in Q1 2018, closing a stake of 14,656 shares — an estimated $3.3M sold.

Highbridge Capital Management first reported a position in ELV in Q3 2013 and held it in 12 quarters. The position peaked at $30.1M in Q2 2016. 924 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

Highbridge Capital Management reported no remaining Elevance Health position as of Q1 2018 after selling out during the quarter.
Highbridge Capital Management sold 14,656 Elevance Health shares in Q1 2018, an estimated $3.3M.
Highbridge Capital Management first reported a position in Elevance Health in Q3 2013 and held it in 12 quarters.
Highbridge Capital Management's Elevance Health position peaked at $30.1M in Q2 2016.
924 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on Highbridge Capital Management's 13F filing for Q1 2018, filed 15 May 2018.